A pilot study on the effect of BCG vaccination in patients with bronchial carcinoma.
Eight patients with non-resectable bronchial carcinoma were treated with a combination of cyclophosphamide and BCG. No effect on survival was noted; mean survival was 11 months from the first admission to hospital.
D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000628:therapy*; D002277:Carcinoma / Q000188:drug therapy / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D014374:Tuberculin Test
D001500:BCG Vaccine; D003520:Cyclophosphamide